Healthcare Stocks Under the Spotlight: Sarepta Therapeutics, Zimmer Biomet Holdings, and Eli Lilly & Co.

Analysts have mixed opinions on healthcare stocks Sarepta Therapeutics, Zimmer Biomet Holdings, and Eli Lilly & Co. Barclays analyst Gena Wang maintained a Buy rating on Sarepta Therapeutics with a $29.00 price target, while analyst Matt Miksic maintained a Sell rating on Zimmer Biomet Holdings with a $112.00 price target. Eli Lilly & Co received no analyst updates.

Analysts have presented mixed opinions on healthcare stocks Sarepta Therapeutics, Zimmer Biomet Holdings, and Eli Lilly & Co. [1]

Barclays analyst Gena Wang maintained a Buy rating on Sarepta Therapeutics with a $29.00 price target. Wang cited the company's promising pipeline and potential for growth as reasons for the positive outlook. However, Sarepta Therapeutics faces a class action lawsuit for alleged securities law violations, which could impact its stock performance [2].

In contrast, analyst Matt Miksic maintained a Sell rating on Zimmer Biomet Holdings with a $112.00 price target. Miksic's concerns include the company's recent acquisition of Monogram Technologies, which may not provide immediate revenue benefits and could strain financial resources. Additionally, Zimmer Biomet faces a patent infringement lawsuit from Treace Medical Concepts [3].

Eli Lilly & Co received no analyst updates, but the stock closed at $771.75 on July 1, 2025, down 3.45% from the previous trading session. The stock underperformed the S&P 500, which registered a daily loss of 0.4%, and the Dow, which lost 0.98% [4].

References:
[1] https://www.morningstar.com/news/pr-newswire/20250714la29229/srpt-shareholders-have-the-right-to-lead-the-sarepta-therapeutics-inc-securities-lawsuit-contact-the-djs-law-group-before-the-final-deadline-srpt
[2] https://www.marketbeat.com/stocks/NYSE/ZBH/
[3] https://www.investing.com/news/analyst-ratings/citi-maintains-neutral-rating-on-zimmer-biomet-stock-amid-monogram-acquisition-93CH-4134119
[4] https://finance.yahoo.com/news/eli-lilly-lly-dips-more-214503427.html